Imperial College London


Faculty of MedicineDepartment of Immunology and Inflammation

Honorary Clinical Senior Lecturer



+44 (0)20 3313 8438e.terpos




Commonwealth BuildingHammersmith Campus






Kumar SK, Dimopoulos MA, Kastritis E, et al., 2017, Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study., Leukemia, Vol:31, Pages:2443-2448

Kostopoulos IV, Paterakis G, Pavlidis D, et al., 2017, Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis, Blood Cancer Journal, Vol:7, ISSN:2044-5385

Spanoudakis E, Papoutselis M, Terpos E, et al., 2016, Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma, Blood Cancer Journal, Vol:6, ISSN:2044-5385

Engert A, Balduini C, Brand A, et al., 2016, The European Hematology Association Roadmap for European Hematology Research: a consensus document., Haematologica, Vol:101, ISSN:0390-6078, Pages:115-208


Rifkin RM, Davies FE, Palumbo A, et al., 2016, Global, Prospective, Non-Interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients: The Insight-MM Study, 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), AMER SOC HEMATOLOGY, ISSN:0006-4971

More Publications